SARAH SEVILLA: Open Payments
NPI 1366132995 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,703 in 60 payments from 20 companies in 2025. Trend: 2023 $619 · 2024 $1,404 · 2025 $1,703
Food & beverage: $1,703
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $273 |
| Astellas Pharma US Inc | 2 | $263 |
| Sumitomo Pharma America, Inc. | 14 | $259 |
| Abbott Laboratories | 1 | $141 |
| Telix Pharmaceuticals | 4 | $108 |
| PFIZER INC. | 5 | $96 |
| UROGEN PHARMA, INC. | 4 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| Dendreon Pharmaceuticals LLC | 2 | $62 |
| Merck Sharp & Dohme LLC | 2 | $56 |
Products named: ERLEADA, XTANDI, CARDIOMEMS, Padcev, GEMTESA, ORGOVYX, ILLUCCIX, Nubeqa.
Industry payments across NV — which companies pay providers there.
